The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | Common | 00287Y109 | 695,649 | 11,029,800 | SH | SOLE | 10,767,500 | 0 | 262,300 | ||
| ALKERMES PLC | SHS | G01767105 | 355,031 | 7,549,033 | SH | SOLE | 7,357,733 | 0 | 191,300 | ||
| NORTHWEST BIOTHERAPEUTICS INC | Common | 66737P600 | 14,062 | 25,915,937 | SH | SOLE | 24,815,028 | 0 | 1,100,909 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 617,384 | 10,301,751 | SH | SOLE | 9,931,090 | 0 | 370,661 | ||
| REYNOLDS AMERICAN INC | Common | 761713106 | 358,732 | 7,608,324 | SH | SOLE | 7,608,324 | 0 | 0 | ||
| THERAVANCE BIOPHARMA INC | Common | G8807B106 | 340,915 | 9,407,137 | SH | SOLE | 9,000,546 | 0 | 406,591 | ||
| BIOGEN INC | Common | 09062X103 | 53,350 | 170,430 | SH | SOLE | 170,430 | 0 | 0 | ||
| GILEAD SCIENCES INC | Common | 375558103 | 38,516 | 486,800 | SH | SOLE | 486,800 | 0 | 0 | ||